✦ LIBER ✦

Discovery, oral pharmacokinetics and in vivo efficacy of velusetrag, a highly selective 5-HT4 receptor agonist that has achieved proof-of-concept in patients with chronic idiopathic constipation

✍ Scribed by Long, Daniel D.; Armstrong, Scott R.; Beattie, David T.; Choi, Seok-Ki; Fatheree, Paul R.; Gendron, Roland A.L.; Genov, Daniel; Goldblum, Adam A.; Humphrey, Patrick P.; Jiang, Lan; Marquess, Daniel G.; Shaw, Jeng-Pyng; Smith, Jacqueline A.M.; Turner, S. Derek; Vickery, Ross G.

Book ID: 123121050
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 434 KB
Volume: 22
Category: Article
ISSN: 0960-894X
DOI: 10.1016/j.bmcl.2012.08.051

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Discovery, oral pharmacokinetics and in

Discovery, oral pharmacokinetics and in vivo efficacy of a highly selective 5-HT4 receptor agonist: Clinical compound TD-2749

✍ Daniel D. Long; Scott R. Armstrong; David T. Beattie; Seok-Ki Choi; Paul R. Fath 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 548 KB

ChemInform Abstract: Discovery, Oral Pha

ChemInform Abstract: Discovery, Oral Pharmacokinetics and in vivo Efficacy of a Highly Selective 5-HT 4 Receptor Agonist: Clinical Compound TD-2749.

✍ Long, Daniel D.; et al., et al. 📂 Article 📅 2012 🏛 John Wiley and Sons ⚖ 21 KB

Clinical trial: the efficacy and tolerab

Clinical trial: the efficacy and tolerability of velusetrag, a selective 5-HT4 agonist with high intrinsic activity, in chronic idiopathic constipation – a 4-week, randomized, double-blind, placebo-controlled, dose–response study

✍ M. Goldberg; Y.-P. Li; J. F. Johanson; A. W. Mangel; M. Kitt; D. T. Beattie; K. 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 311 KB